[ Price : $8.95]
FDA approves a Lexicon Pharmaceuticals NDA for Inpefa (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascul...[ Price : $8.95]
Federal Register notice: FDA determines that Purdue Pharmas Chirocaine (levobupivacaine) injection was not withdrawn due to safety...[ Price : $8.95]
Mirati Therapeutics says its sitravatinib failed to meet the primary endpoint in the Phase 3 SAPPHIRE lung cancer study.[ Price : $8.95]
FDA publishes a guidance with recommendations to help manufacturers comply with the special controls related to non-clinical perfo...[ Price : $8.95]
FDA publishes a guidance with its recommendations on adjusting for covariates in the statistical analysis of randomized clinical t...[ Price : $8.95]
The latest Sedgwick recall index report details increases in drug and medical device recalls in the first quarter of 2023 over the...[ Price : $8.95]
FDA grants Human Immunology Biosciences an orphan drug designation for felzartamab, an investigational agent for treating primary ...[ Price : $8.95]
Michigan members of the House of Representatives urge quick FDA action to address shortages of three chemotherapy drugs.